Genmab A/S
ANTIBODIES
Last updated:
Abstract:
The present invention relates to antibodies binding to 5T4, including bispecific antibodies binding to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2020
Issue date:
11 Mar 2021